Veronica Lunerti
Camerino, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in Rats.
Journal: The American journal of psychiatry
Published: January 15, 2025
A multi-symptomatic model of heroin use disorder in rats reveals distinct behavioral profiles and neuronal correlates of heroin vulnerability versus resiliency.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
Predicting individual treatment response in alcohol use disorders: a reverse translational proof-of-concept study.
Journal: Translational psychiatry
Published: July 12, 2024
Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats.
Journal: Molecular psychiatry
Published: June 25, 2024
Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2024
Long-access heroin self-administration induces region specific reduction of grey matter volume and microglia reactivity in the rat.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy.
Journal: Neuropharmacology
Published: February 22, 2024
Long-access heroin self-administration induces region specific reduction of grey matter volume and microglia reactivity in the rat.
Journal: Brain, behavior, and immunity
Published: October 05, 2023
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy.
Journal: bioRxiv : the preprint server for biology
Published: August 07, 2023
The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats.
Journal: European journal of pharmacology
Published: December 01, 2021
Network-Based Discovery of Opioid Use Vulnerability in Rats Using the Bayesian Stochastic Block Model.
Journal: Frontiers in psychiatry
Published: July 23, 2021
Last Updated: 09/26/2026